Datopotamab Deruxtecan [2238831-60-0]
82921
TargetTACSTD2
Product group Antibodies
Overview
- SupplierBPS Bioscience
- Product NameDatopotamab Deruxtecan [2238831-60-0]
- Delivery Days Customer23
- CAS Number2238831-60-0
- CertificationResearch Use Only
- ClonalityMonoclonal
- Estimated Purity≥90%
- Gene ID4070
- Target nameTACSTD2
- Target descriptiontumor associated calcium signal transducer 2
- Target synonymsEGP-1, EGP1, GA733-1, GA7331, GP50, M1S1, TROP2, tumor-associated calcium signal transducer 2, 40kD glycoprotein, identified by monoclonal antibody GA733, cell surface glycoprotein TROP2, cell surface glycoprotein Trop-2, epithelial glycoprotein-1, gastrointestinal tumor-associated antigen GA7331, membrane component, chromosome 1, surface marker 1, pancreatic carcinoma marker protein GA733-1, pancreatic carcinoma marker protein GA7331, trophoblast cell surface antigen 2
- Protein IDP09758
- Protein NameTumor-associated calcium signal transducer 2
- Scientific DescriptionDatopotamab deruxtecan (DS-1062; Dato-DXd) is a trophoblast cell surface antigen 2 (TROP2)-directed antibody-drug conjugate (ADC). Datopotamab deruxtecan has a potent antitumor activity.1
- Storage Instruction-80°C
- UNSPSC41116161
- SpeciesHuman







![IHC-P analysis of human renal cortex tissue using GTX04443 TACSTD2 antibody [MSVA-733R] HistoMAX?. Kidney cortex In the kidney TACSTD2 immunostaining is strong in distal tubuli and collecting ducts but weaker in the parietal layer of the Bowman capsule.](https://www.genetex.com/upload/website/prouct_img/normal/GTX04443/GTX04443_20230728_IHC-P_114_23072722_413.webp)